Heike Wulff Selected Research

Picrotoxin

1/2020	Susceptibility of larval zebrafish to the seizurogenic activity of GABA type A receptor antagonists.
1/2020	Comparison of the toxicokinetics of the convulsants picrotoxinin and tetramethylenedisulfotetramine (TETS) in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Heike Wulff Research Topics

Disease

16	Autoimmune Diseases (Autoimmune Disease) 08/2020 - 09/2003
12	Inflammation (Inflammations) 04/2023 - 06/2007
9	Neuroinflammatory Diseases 06/2023 - 12/2016
9	Seizures (Absence Seizure) 01/2023 - 01/2016
8	Ischemic Stroke 04/2023 - 12/2011
7	Alzheimer Disease (Alzheimer's Disease) 12/2021 - 01/2017
7	Neoplasms (Cancer) 09/2019 - 01/2013
6	Infarction (Infarctions) 04/2023 - 01/2007
6	Stroke (Strokes) 01/2023 - 12/2011
6	Multiple Sclerosis 05/2009 - 04/2004
5	Ataxia (Dyssynergia) 01/2022 - 01/2007
4	Pain (Aches) 02/2024 - 01/2015
4	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 04/2023 - 12/2011
4	Hypertension (High Blood Pressure) 01/2023 - 02/2009
4	Fibrosis (Cirrhosis) 04/2022 - 08/2009
4	Ischemia 01/2018 - 12/2011
4	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2014 - 07/2007
4	Asthma (Bronchial Asthma) 10/2013 - 08/2009
3	Sickle Cell Anemia (Hemoglobin S Disease) 04/2023 - 01/2007
3	Status Epilepticus (Complex Partial Status Epilepticus) 01/2023 - 01/2020
3	Cerebellar Ataxia (Dysmetria) 01/2022 - 10/2013
3	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2022 - 08/2015
3	Hyperplasia 01/2020 - 09/2003
3	Epilepsy (Aura) 07/2017 - 01/2007
3	Idiopathic Pulmonary Fibrosis 01/2015 - 01/2013
3	Rheumatoid Arthritis 12/2010 - 11/2006
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2007 - 12/2004
2	Nervous System Diseases (Neurological Disorders) 02/2024 - 06/2023
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 07/2017
2	Cognitive Dysfunction 01/2023 - 01/2020
2	Atherosclerosis 01/2023 - 09/2008
2	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2022 - 01/2017
2	Parkinson Disease (Parkinson's Disease) 12/2021 - 01/2007
2	Traumatic Brain Injuries (Traumatic Brain Injury) 12/2021 - 01/2012
2	Cardiac Arrhythmias (Arrythmia) 01/2021 - 01/2021
2	Gliosis 11/2020 - 01/2017
2	Brain Neoplasms (Brain Tumor) 02/2019 - 01/2018
2	Hypoxia (Hypoxemia) 01/2018 - 01/2018
2	Glioma (Gliomas) 01/2018 - 05/2016
2	Amyloid Plaque 01/2017 - 02/2011
2	Brain Edema (Cerebral Edema) 01/2017 - 01/2015
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2015 - 01/2013
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2014 - 01/2010
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 07/2007 - 11/2006
1	Disease Progression 01/2023
1	Reperfusion Injury 01/2023

Drug/Important Bio-Agent (IBA)

17	TRAM 34IBA 01/2022 - 09/2003
12	Potassium Channels (Potassium Channel)IBA 01/2023 - 12/2004
9	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 01/2023 - 01/2002
7	Peptides (Polypeptides)IBA 02/2024 - 04/2005
6	senicapocIBA 04/2023 - 01/2007
5	CytokinesIBA 04/2023 - 06/2007
5	Ion Channels (Ion Channel)IBA 01/2020 - 01/2002
4	Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA 04/2023 - 09/2003
4	BenzodiazepinesIBA 01/2022 - 06/2016
4	CalciumIBA 01/2022 - 12/2011
4	Kv1.3 Potassium ChannelIBA 12/2021 - 11/2006
4	tetramethylenedisulfotetramine (DSTA)IBA 01/2021 - 01/2020
4	Amyloid (Amyloid Fibrils)IBA 04/2019 - 02/2011
4	naphtho(1,2-d)thiazol-2-ylamineIBA 07/2014 - 02/2009
4	CollagenIBA 02/2013 - 09/2003
3	SodiumIBA 02/2024 - 12/2022
3	Midazolam (Versed)FDA LinkGeneric 01/2023 - 06/2016
3	PotassiumIBA 01/2022 - 09/2014
3	ConvulsantsIBA 01/2021 - 01/2020
3	Immunologic Factors (Immunomodulators)IBA 01/2018 - 06/2004
3	Proteins (Proteins, Gene)FDA Link 01/2015 - 02/2011
2	Spider Venoms (Venom, Spider)IBA 02/2024 - 06/2023
2	Epoxide HydrolasesIBA 06/2023 - 08/2014
2	Riluzole FDA LinkGeneric 01/2023 - 10/2013
2	LipidsIBA 01/2023 - 06/2016
2	Interleukin-6 (Interleukin 6)IBA 01/2023 - 01/2020
2	cyclonite (RDX)IBA 01/2023 - 01/2022
2	Aminobutyrates (Aminobutyric Acid)IBA 01/2023 - 01/2021
2	CholesterolIBA 01/2023 - 09/2008
2	ChloridesIBA 01/2023 - 09/2008
2	Minocycline (Cyclops)FDA LinkGeneric 01/2022 - 01/2018
2	Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA 01/2022 - 08/2015
2	Isoflurophate (DFP)FDA Link 11/2020 - 01/2016
2	Diazepam (Valium)FDA LinkGeneric 11/2020 - 06/2016
2	PicrotoxinIBA 01/2020 - 01/2020
2	4- ((3- (trifluoromethyl)phenyl)methyl)- 2H- 1,4- benzothiazin- 3(4H)- oneIBA 01/2018 - 01/2013
2	Glutamic Acid (Glutamate)FDA Link 01/2018 - 02/2015
2	Fatty Acids (Saturated Fatty Acids)IBA 06/2016 - 08/2014
2	Neuroprotective AgentsIBA 01/2016 - 01/2012
2	Angiotensin IIIBA 09/2015 - 02/2009
2	polyglutamineIBA 08/2015 - 09/2011
2	Interleukin-17 (Interleukin 17)IBA 11/2014 - 06/2007
2	Intermediate-Conductance Calcium-Activated Potassium ChannelsIBA 05/2013 - 09/2008
2	ApaminIBA 02/2013 - 01/2007
2	Potassium Channel Blockers (Blockers, Potassium Channel)IBA 09/2008 - 02/2007
1	Aflatoxin B1 (Aflatoxin B)IBA 06/2023
1	SynucleinsIBA 06/2023
1	Dihydrotachysterol (AT 10)IBA 04/2023
1	Zolpidem (Ambien)FDA LinkGeneric 01/2023
1	Superoxide Dismutase-1IBA 01/2023

Therapy/Procedure

24	Therapeutics 02/2024 - 09/2003
3	Immunomodulation 01/2019 - 04/2005
2	Radiotherapy 02/2019 - 05/2016
2	Immunotherapy 12/2014 - 01/2013